Treatment against overweight could reduce risk of type 2 diabetes
The risk of type 2 diabetes is reduced by more than half by weekly injections of the new obesity drug Wegovy (semaglutide). This is according to new research being presented…
The risk of type 2 diabetes is reduced by more than half by weekly injections of the new obesity drug Wegovy (semaglutide). This is according to new research being presented…